Cryopyrin-associated periodic syndrome epidemiology and demographics
|
Cryopyrin-associated periodic syndrome Microchapters |
|
Differentiating Cryopyrin-associated periodic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cryopyrin-associated periodic syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cryopyrin-associated periodic syndrome epidemiology and demographics |
|
FDA on Cryopyrin-associated periodic syndrome epidemiology and demographics |
|
CDC on Cryopyrin-associated periodic syndrome epidemiology and demographics |
|
Cryopyrin-associated periodic syndrome epidemiology and demographics in the news |
|
Blogs on Cryopyrin-associated periodic syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence cryopyrin-associated periodic syndrom is approximately 0.0343 per 100,000 individuals aged 16 years old or younger worldwide.[1]
Prevalence
- The prevalence of cryopyrin-associated periodic syndrom is approximately 0.1 per 100,000 individuals worldwide.[2]
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Lainka, E.; Neudorf, U.; Lohse, P.; Timmann, C.; Bielak, M.; Stojanov, S.; Huss, K.; Kries, R. von; Niehues, T. (2010). "Analysis of Cryopyrin-Associated Periodic Syndromes (CAPS) in German Children: Epidemiological, Clinical and Genetic Characteristics". Klinische Pädiatrie. 222 (06): 356–361. doi:10.1055/s-0030-1265181. ISSN 0300-8630.
- ↑ Mehr, Sam; Allen, Roger; Boros, Christina; Adib, Navid; Kakakios, Alyson; Turner, Paul J; Rogers, Maureen; Zurynski, Yvonne; Singh-Grewal, Davinder (2016). "Cryopyrin-associated periodic syndrome in Australian children and adults: Epidemiological, clinical and treatment characteristics". Journal of Paediatrics and Child Health. 52 (9): 889–895. doi:10.1111/jpc.13270. ISSN 1034-4810.